Wenbo Xu Selected Research

Wenbo Xu Research Topics

Disease

19	Infections 03/2023 - 02/2010
15	Poliomyelitis (Polio) 01/2023 - 09/2006
14	Measles 10/2020 - 08/2009
13	COVID-19 03/2023 - 01/2020
9	Neoplasms (Cancer) 04/2024 - 04/2011
8	acute flaccid myelitis 01/2023 - 02/2010
8	Rubella (German Measles) 12/2017 - 07/2011
3	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2018 - 01/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 03/2023
2	Human Influenza (Influenza) 12/2022 - 07/2022
2	Paralysis (Palsy) 11/2022 - 09/2006
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
2	Fever (Fevers) 01/2021 - 12/2019
2	Exanthema (Rash) 10/2020 - 01/2018
2	Chickenpox 01/2019 - 10/2016
2	Mumps 11/2018 - 01/2017
1	Neuroinflammatory Diseases 02/2024
1	Metabolic Diseases (Metabolic Disease) 12/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Tick Bites 01/2023
1	Lymphatic Metastasis 01/2023
1	Aneuploidy (Aneuploid) 12/2022
1	Dyspnea (Shortness of Breath) 12/2022
1	Lymphopenia (Lymphocytopenia) 12/2022
1	Glioma (Gliomas) 11/2022
1	Lethargy 11/2022
1	Epilepsy (Aura) 10/2022
1	Paramyxoviridae Infections (Parainfluenza) 07/2022
1	Hepatocellular Carcinoma (Hepatoma) 07/2022
1	Breakthrough Infections 05/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Triploidy 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Aseptic Meningitis 12/2021
1	Diarrhea 01/2021

Drug/Important Bio-Agent (IBA)

47	VaccinesIBA 03/2023 - 09/2006
9	Proteins (Proteins, Gene)FDA Link 03/2023 - 12/2006
8	Neutralizing AntibodiesIBA 03/2023 - 11/2010
7	NucleotidesIBA 12/2014 - 12/2006
6	Immunoglobulin G (IgG)IBA 10/2022 - 12/2017
5	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 07/2022 - 06/2016
4	Immunoglobulin M (IgM)IBA 11/2018 - 09/2009
3	Nucleic AcidsIBA 07/2022 - 01/2018
3	Measles VaccineIBA 10/2020 - 08/2009
3	Rubella VaccineIBA 12/2017 - 02/2012
2	LipidsIBA 12/2023 - 04/2011
2	N-(2-cyanoethylene)urea (BA 1)IBA 03/2023 - 12/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 12/2022
2	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 01/2023 - 05/2017
2	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2023 - 01/2021
2	dichlorobis(azomycin)platinum IIIBA 12/2022 - 01/2022
2	Complement System Proteins (Complement)IBA 11/2022 - 12/2021
2	CytokinesIBA 06/2022 - 09/2011
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 10/2016
2	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2013
2	EnzymesIBA 01/2020 - 01/2018
2	ImmunosorbentsIBA 01/2020 - 01/2018
2	antineoplaston A10 (A 10)IBA 01/2018 - 01/2014
2	Amino Acids FDA Link 12/2016 - 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	LipopolysaccharidesIBA 02/2024
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	Peptides (Polypeptides)IBA 03/2023
1	Protein Subunit VaccinesIBA 03/2023
1	BerberineIBA 03/2023
1	Viral RNAIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	AntigensIBA 12/2022
1	Monoclonal AntibodiesIBA 12/2022
1	FurinIBA 12/2022
1	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2022
1	WZ16IBA 11/2022
1	AntibodiesIBA 10/2022
1	Transcription Factors (Transcription Factor)IBA 10/2022
1	Interleukin-6 (Interleukin 6)IBA 06/2022
1	COVID-19 VaccinesIBA 05/2022
1	BNT162 VaccineIBA 04/2022
1	Viral VaccinesIBA 04/2022
1	sinovac COVID-19 vaccineIBA 04/2022
1	mRNA VaccinesIBA 04/2022
1	matrigelIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Long Noncoding RNAIBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	Sincalide FDA Link 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 12/2021
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 12/2021
1	Recombinant ProteinsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021

Therapy/Procedure

2	Immunotherapy 12/2023 - 01/2019
2	Therapeutics 01/2022 - 01/2019
1	Drug Therapy (Chemotherapy) 04/2024
1	Injections 01/2023
1	Length of Stay 12/2022